Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT05974358

KONO-S Anastomosis Compared to Conventional Ileocolonic Anastomosis to Reduce Recurrence in Crohn's Disease

Led by Centre Hospitalier Universitaire de Besancon · Updated on 2025-02-13

226

Participants Needed

15

Research Sites

204 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) currently affecting one person in a thousand in France. It can lead to numerous digestive complications such as fistulas, abscesses or stenosis. Despite numerous therapeutic advances, the rate of patients requiring surgery remains very high, with approximately 50% requiring at least one surgical intervention at 10 years after disease diagnosis. However, surgical treatment is not curative, the postoperative recurrence rate being very high, from 65 to-90% endoscopic recurrence at 1 year. The ileocolonic anastomosis is the main site of postoperative recurrence currently defined by a Rutgeerts score (≥i2) 6 months after surgery. In 2003, Kono et al. described a new operative technique that could reduce the rate of post-operative recurrence: a termino-terminal ileocolonic anastomosis, anti-mesenteric, with a supporting column to prevent distortion and anastomotic stenosis (Kono-S anastomosis). The study showed no decrease in endoscopic recurrence rate at 1 year (83% vs 79%), but a significant decrease in surgical recurrence rate at 5 years (15% vs 0%). Recently, a randomized Italian monocenter study showed a significant decrease in endoscopic recurrence rate at 6 and 18 months (22.2% versus 62.8% and 25% versus 67.4%), as well as a decrease in clinical recurrence. The limitations of this study are its monocentric nature and the lack of centralization of the endoscopic analysis to assess the primary endpoint. This surgical technique has been performed in some centers for ileocolonic Crohn's surgery since 2020. Nevertheless, the level of evidence remains too low to establish practice recommendations. The KOALA study will be the first prospective, multicenter, randomized study comparing KONO-S anastomosis and conventional anastomosis for ileocolonicresection of Crohn's disease, with blinded and centralized evaluation of recurrence.

CONDITIONS

Official Title

KONO-S Anastomosis Compared to Conventional Ileocolonic Anastomosis to Reduce Recurrence in Crohn's Disease

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patient 18 years and older up to 75 years
  • Diagnosis of Crohn's disease
  • Requiring a first ileocolonic resection due to fistulizing, abscessed, stenosing disease or disease resistant to medical treatment
  • Affiliated with the French social security system
Not Eligible

You will not qualify if you...

  • Previous ileocolonic resection
  • Contraindication to postoperative endoscopy
  • Planned defunctioning protective stoma with anastomosis
  • Emergency surgery such as peritonitis
  • Lack of consent to participate in the study
  • Pregnancy
  • Refusal or inability to provide informed consent
  • Under legal protection or guardianship by court order

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 15 locations

1

CHu de Besançon

Besançon, France, 25030

Actively Recruiting

2

CHU de Bordeaux

Bordeaux, France

Not Yet Recruiting

3

CHU de Grenoble

Grenoble, France

Not Yet Recruiting

4

CHU de Lille Hopital Claude Huriez

Lille, France

Not Yet Recruiting

5

HCL-Hôpital Lyon Sud

Lyon, France

Not Yet Recruiting

6

AP-HM Hôpital Nord

Marseille, France

Not Yet Recruiting

7

CHU de Nançy

Nancy, France

Not Yet Recruiting

8

CHU de Nantes

Nantes, France

Not Yet Recruiting

9

Ap-HP Hopital St Louis

Paris, France

Not Yet Recruiting

10

AP-HP Hôpital Européen Georges Pompidou

Paris, France

Not Yet Recruiting

11

AP-HP Le Kremlin-Bicetre

Paris, France

Not Yet Recruiting

12

AP-HP St Antoine

Paris, France

Not Yet Recruiting

13

CHU de Rennes

Rennes, France

Not Yet Recruiting

14

CHU de Strasbourg HautePierre

Strasbourg, France

Not Yet Recruiting

15

CHU de Toulouse

Toulouse, France

Not Yet Recruiting

Loading map...

Research Team

Z

Zaher LAKKIS

CONTACT

A

Astrid POZET

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here